Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years w...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2009-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/5455 |
| _version_ | 1797255356617850880 |
|---|---|
| author | Elena Efimovna Petryaykina Olga Viktorovna Dukhareva Irina Georgievna Rybkina Ekaterina Alexandrovna Pronina Tatiana Dmitrievna Mikhaylova Irina Viktorovna Garyaeva Eleonora Tavanovna Mandzhieva Igor Eduardovich Volkov Natalya Mikhailovna Grenkova |
| author_facet | Elena Efimovna Petryaykina Olga Viktorovna Dukhareva Irina Georgievna Rybkina Ekaterina Alexandrovna Pronina Tatiana Dmitrievna Mikhaylova Irina Viktorovna Garyaeva Eleonora Tavanovna Mandzhieva Igor Eduardovich Volkov Natalya Mikhailovna Grenkova |
| author_sort | Elena Efimovna Petryaykina |
| collection | DOAJ |
| description | Aim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (p |
| first_indexed | 2024-03-08T15:22:24Z |
| format | Article |
| id | doaj.art-74cebe09b5b9493a9ff7a5c25c49416b |
| institution | Directory Open Access Journal |
| issn | 2072-0351 2072-0378 |
| language | English |
| last_indexed | 2024-04-24T22:04:33Z |
| publishDate | 2009-09-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj.art-74cebe09b5b9493a9ff7a5c25c49416b2024-03-20T11:47:54ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782009-09-01123606310.14341/2072-0351-54555413Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow regionElena Efimovna Petryaykina0Olga Viktorovna Dukhareva1Irina Georgievna Rybkina2Ekaterina Alexandrovna Pronina3Tatiana Dmitrievna Mikhaylova4Irina Viktorovna Garyaeva5Eleonora Tavanovna Mandzhieva6Igor Eduardovich Volkov7Natalya Mikhailovna Grenkova8Morozov Children’s Clinical HospitalEndocrinological Dispensary, Moscow Health Department, MoscowMorozov Children’s Clinical HospitalMorozov Children’s Clinical HospitalMorozov Children’s Clinical HospitalRussian State Medical University, MoscowRussian State Medical University, MoscowRepublican Children’s Clinical Hospital, MoscowRepublican Children’s Clinical Hospital, MoscowAim. To assess dynamics of glycated hemoglobin levels and insulin doses per kg bw in children and adolescents with poorly controlled type 1 diabetes mellitus using insulin pumps. Materials and methods. Retrospective analysis of HbA1c levels and insulin doses per kg bw in children aged 2-17 years with DM1 (mean duration 5.3?3.1) before and 18 months after onset of insulin pump therapy (Medtronic Minimed 712 and 722) with a short-acting insulin analog Novopramid (Novo Nordisk) or Humalog (Ely Lilly) given to 55 (52,4%) and 50 (47,6%) of the patients respectively. НbА1с level and mean daily insulin dose per kg bw were determined when a patient visited the doctors office every 3 months. Results. Insulin pump therapy in patients with initially poorly controlled DM1 resulted in a decrease of HbA1c from 9.8?0.8 to 7,8?0,5% within 18 months after its beginning (phttps://www.dia-endojournals.ru/jour/article/view/5455type 1 diabetes mellituschildren and adolescentsinsulin pump therapyglycated hemoglobininsulin requirementefficiency of therapy |
| spellingShingle | Elena Efimovna Petryaykina Olga Viktorovna Dukhareva Irina Georgievna Rybkina Ekaterina Alexandrovna Pronina Tatiana Dmitrievna Mikhaylova Irina Viktorovna Garyaeva Eleonora Tavanovna Mandzhieva Igor Eduardovich Volkov Natalya Mikhailovna Grenkova Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region Сахарный диабет type 1 diabetes mellitus children and adolescents insulin pump therapy glycated hemoglobin insulin requirement efficiency of therapy |
| title | Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region |
| title_full | Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region |
| title_fullStr | Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region |
| title_full_unstemmed | Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region |
| title_short | Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region |
| title_sort | insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the moscow region |
| topic | type 1 diabetes mellitus children and adolescents insulin pump therapy glycated hemoglobin insulin requirement efficiency of therapy |
| url | https://www.dia-endojournals.ru/jour/article/view/5455 |
| work_keys_str_mv | AT elenaefimovnapetryaykina insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT olgaviktorovnadukhareva insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT irinageorgievnarybkina insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT ekaterinaalexandrovnapronina insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT tatianadmitrievnamikhaylova insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT irinaviktorovnagaryaeva insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT eleonoratavanovnamandzhieva insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT igoreduardovichvolkov insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion AT natalyamikhailovnagrenkova insulinpumptherapyoftype1diabetesmellitusinchildrenandadolescentsinthemoscowregion |